Dabigatran
- Generic Name
- Dabigatran
- Brand Names
- Dabigatran Etexilate Leon Farma, Dabigatran Etexilate Accord, Pradaxa
- Drug Type
- Small Molecule
- Chemical Formula
- C25H25N7O3
- CAS Number
- 211914-51-1
- Unique Ingredient Identifier
- I0VM4M70GC
- Background
Dabigatran is the active form of the orally bioavailable prodrug dabigatran etexilate.
- Associated Conditions
- -
- Associated Therapies
- -
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 5350
- Registration Number
- NCT04735523
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Malmö University
- Target Recruit Count
- 216
- Registration Number
- NCT04662515
- Locations
- 🇸🇪
Skåne University Hospital, Helsingborg, Sweden
🇸🇪Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University, Malmö, Sweden
Anticoagulation in Patients With Venous Thromboembolism and Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT04618913
- Locations
- 🇬🇧
Pfizer Investigational Site, London, United Kingdom
Replication of the RELY Anticoagulant Trial in Healthcare Claims Data
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 78140
- Registration Number
- NCT04593043
- Locations
- 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States
ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 898
- Registration Number
- NCT04532528
- Locations
- 🇨🇳
Buddhist Tzu Chi General Hospital, Hualien, Taiwan
🇨🇳National Taiwan University Hospital-Hsin-Chu Branch, Hsinchu, Taiwan
🇨🇳Pingtung Christian Hospital, Pingtung, Taiwan
Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 89
- Registration Number
- NCT04498741
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc.,, Lenexa, Kansas, United States
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
- Conditions
- Interventions
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 84
- Registration Number
- NCT04433481
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
- Conditions
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2023-06-06
- Target Recruit Count
- 700
- Registration Number
- NCT04297150
- Locations
- 🇪🇸
Hospital Universitario de La Princesa, Madrid, Spain
🇪🇸Hospital Gómez Ulla, Madrid, Spain
🇪🇸Hospital Universitario de La Paz, Madrid, Spain
Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
- Conditions
- Interventions
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 134897
- Registration Number
- NCT04249401
- Locations
- 🇸🇪
Many locations, Multiple Locations, Sweden
DOAC Versus VKA After Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Laval University
- Registration Number
- NCT04002011
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.